Read + Share
Amedeo Smart
Independent Medical Education
Daunt A, Perez-Guzman PN, Liew F, Hauck K, et al. Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease. J Infect 2020 Jun 21. pii: S0163-4453(20)30430.PMID: 32579980
Email
LinkedIn
Facebook
Twitter
Privacy Policy